
The novel coronavirus (SARS-CoV-2) and its many mutations, such as the Omicron variant, is currently spreading rapidly throughout the globe and is exerting a detrimental effect on the greater populace and their general quality of life.
To combat the virus and aid in vaccine development, contact tracing, and virus research, the whole genome sequence analysis of SARS-CoV-2 has become necessary.
Celemics has developed reagents and bioinformatics software specifically optimized to amplify the SARS-CoV-2 whole genome sequence, resulting in the provision of high-quality analysis results of the viral whole genome sequence within 24 hours.